Erik Walldén has +30 years of international life science industry management. Previously, he is the CEO of Gyros, Affibody Holding, Biacore International, and Pyrosequencing and has held senior positions at PerSeptive Biosystems, Pharmacia Biosensor, and Pharmacia Biotech.